(Q43851678)

27 November 2017

title

Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis (English)

1 reference

27 November 2017

1 reference

4

1 reference

27 November 2017

6

1 reference

27 November 2017

Jordi Vila

5

0 references

author name string

Javier Fernández

1

1 reference

27 November 2017

Miquel Navasa

2

1 reference

27 November 2017

Juliá Gómez

3

1 reference

27 November 2017

Juan Rodés

7

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

27 November 2017

1 reference

27 November 2017

volume

35

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

140-148

1 reference

A prospective study of bacterial infections in patients with cirrhosis

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30082

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30082

Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30082

Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30082

Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30082

Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30082

Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30082

Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30082

Problems of bacterial infection in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30082

Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30082

Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30082

Spontaneous bacterial peritonitis and empyema by Escherichia coli resistant to norfloxacine in a patient on selective intestinal decontamination with norfloxacine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30082

Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30082

Antibiotic Prophylaxis for the Prevention of Bacterial Infections in Cirrhotic Patients with Ascites: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30082

Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30082

21 January 2018

Identifiers

DOI

10.1053/JHEP.2002.30082

1 reference

27 November 2017

1 reference